Peter Sagmeister
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Peter Sagmeister has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- C. Oliver Kappe
Institute of Chemistry, University of Graz, NAWI Graz, Heinrichstrasse 28, 8010 Graz, Austria
15 shared publications - Jason D. Williams
Center for Continuous Synthesis and Processing (CCFLOW), Research Center Pharmaceutical Engineering GmbH (RCPE), Inffeldgasse 13, 8010 Graz, Austria
15 shared publications - Allan S. Myerson
Massachusetts Institute of Technology 77 Massachusetts Avenue
7 shared publications - Aniket Udepurkar
Massachusetts Institute of Technology 77 Massachusetts Avenue
6 shared publications - Cedric Devos
Massachusetts Institute of Technology 77 Massachusetts Avenue
6 shared publications - Richard D. Braatz
Massachusetts Institute of Technology
6 shared publications
Latest Publications
- 25 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (40) , 27497-27507
Autonomous Lipid Nanoparticle Engineering
Lipid nanoparticles (LNPs) are the leading vehicles for encapsulating and delivering nucleic acid therapeutics. Yet, their process development remains labor-intensive and empirical, constrained by coupled quality attributes and limited mechanistic insight. We present an autonomous, pilot-scale platform for accelerating LNP process development by identifying critical process parameters (CPPs) that produce LNPs with target size attributes. The platform combines a size-control production method with inline dynamic light scattering (DLS) for real-time feedback, enabling closed-loop experimentation and accelerated optimization. With built-in automated design of experiments, dynamic parameter sweeps, and Bayesian optimization, the platform enables rapid, data-rich exploration of complex design spaces. We demonstrate that the platform rapidly maps complex process–property relationships for loaded LNPs, while minimizing experimental burden. The resulting data-rich outputs were used to develop a predictive model that quantitatively links process parameters to particle quality attributes. Operable in fully autonomous mode, the platform provides a scalable and flexible framework for rational LNP manufacturing and accelerates the broader development of nucleic acid therapeutics.
- 25 September 2026
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 20 (40) , 27497-27507
Autonomous Lipid Nanoparticle Engineering
Lipid nanoparticles (LNPs) are the leading vehicles for encapsulating and delivering nucleic acid therapeutics. Yet, their process development remains labor-intensive and empirical, constrained by coupled quality attributes and limited mechanistic insight. We present an autonomous, pilot-scale platform for accelerating LNP process development by identifying critical process parameters (CPPs) that produce LNPs with target size attributes. The platform combines a size-control production method with inline dynamic light scattering (DLS) for real-time feedback, enabling closed-loop experimentation and accelerated optimization. With built-in automated design of experiments, dynamic parameter sweeps, and Bayesian optimization, the platform enables rapid, data-rich exploration of complex design spaces. We demonstrate that the platform rapidly maps complex process–property relationships for loaded LNPs, while minimizing experimental burden. The resulting data-rich outputs were used to develop a predictive model that quantitatively links process parameters to particle quality attributes. Operable in fully autonomous mode, the platform provides a scalable and flexible framework for rational LNP manufacturing and accelerates the broader development of nucleic acid therapeutics.
- 5 August 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 26 (16) , 6523-6532
Particle Engineering in a Continuous Crystallizer Cascade
Crystallization is central to the purification and manufacturing of nearly all small-molecule pharmaceuticals. However, continuous crystallization remains sparsely adopted, in part due to the lack of standardized off-the-shelf platforms (≤100 mL) for reproducible development. This study reports the benchmarking of a continuous tower crystallizer (TWC) that constitutes a cascade of 10 mixed-suspension, mixed-product removal (MSMPR) crystallizers to approach plug-flow-like residence time distribution (RTD) in a compact and robust setup (≤80 mL). Using ketoconazole, an agglomeration-prone active pharmaceutical ingredient (API), as a case study, the TWC’s particle engineering capability is compared to a conventional single-tank MSMPR (with similar total volume) utilized as baseline. The advanced supersaturation control achieved in the cascade enables shifting the broad bimodal crystal size distribution (CSD, D90 = 225 μm, span = 4.5) to a unimodal CSD (D90 = 57 μm, span = 3.2) while significantly increasing process yield from 66% (MSMPR) to 90% (TWC). This tunability was further demonstrated through a proof-of-concept for distributed antisolvent addition in the TWC (D90 = 44 μm, span = 2.7).
- 5 August 2026
- Published by American Chemical Society (ACS) in Crystal Growth & Design
- Vol. 26 (16) , 6523-6532
Particle Engineering in a Continuous Crystallizer Cascade
Crystallization is central to the purification and manufacturing of nearly all small-molecule pharmaceuticals. However, continuous crystallization remains sparsely adopted, in part due to the lack of standardized off-the-shelf platforms (≤100 mL) for reproducible development. This study reports the benchmarking of a continuous tower crystallizer (TWC) that constitutes a cascade of 10 mixed-suspension, mixed-product removal (MSMPR) crystallizers to approach plug-flow-like residence time distribution (RTD) in a compact and robust setup (≤80 mL). Using ketoconazole, an agglomeration-prone active pharmaceutical ingredient (API), as a case study, the TWC’s particle engineering capability is compared to a conventional single-tank MSMPR (with similar total volume) utilized as baseline. The advanced supersaturation control achieved in the cascade enables shifting the broad bimodal crystal size distribution (CSD, D90 = 225 μm, span = 4.5) to a unimodal CSD (D90 = 57 μm, span = 3.2) while significantly increasing process yield from 66% (MSMPR) to 90% (TWC). This tunability was further demonstrated through a proof-of-concept for distributed antisolvent addition in the TWC (D90 = 44 μm, span = 2.7).
- 30 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 2008-2018
Hydrogenation Process Development in a Data-Rich Environment
- 30 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 2008-2018
Hydrogenation Process Development in a Data-Rich Environment
- 25 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 1746-1780
Automation in Pharmaceutical Crystallization
- 25 June 2026
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 30 (7) , 1746-1780
Automation in Pharmaceutical Crystallization
- Open Access
- 27 April 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (18) , 26901-26908
Understanding Size Distributions during Lipid Nanoparticle Manufacturing through Mechanistic Modeling
Recent breakthroughs in messenger RNA (mRNA) therapeutics have highlighted the importance of lipid nanoparticles (LNPs) as delivery vehicles that protect fragile mRNA and facilitate cellular uptake. While manufacturing technologies that rely on self-assembly through mixing, including microfluidic systems and turbulent jet mixers, have enabled scalable production, a first-principles model explaining the fundamental mechanisms responsible for LNP size and its distribution has remained elusive. This has limited predictive process control and optimization. To address this gap, we present here a model based on crystallization of a lipid during turbulent mixing of water–ethanol, employing population balance equations to predict particle size distributions. The model successfully predicts the influence of key operating parameters including total flow rate, flow rate ratio, and lipid concentration, demonstrating favorable comparison with experimental results and enabling the development of predictive manufacturing processes for consistent critical quality attributes. The mechanistic understanding provides the foundation necessary to optimize manufacturing of LNPs used as delivery agents of mRNA vaccines, which extends beyond the current application to the broader field of nucleic acid therapeutics.
- 27 April 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (18) , 26901-26908
Open AccessUnderstanding Size Distributions during Lipid Nanoparticle Manufacturing through Mechanistic Modeling
Recent breakthroughs in messenger RNA (mRNA) therapeutics have highlighted the importance of lipid nanoparticles (LNPs) as delivery vehicles that protect fragile mRNA and facilitate cellular uptake. While manufacturing technologies that rely on self-assembly through mixing, including microfluidic systems and turbulent jet mixers, have enabled scalable production, a first-principles model explaining the fundamental mechanisms responsible for LNP size and its distribution has remained elusive. This has limited predictive process control and optimization. To address this gap, we present here a model based on crystallization of a lipid during turbulent mixing of water–ethanol, employing population balance equations to predict particle size distributions. The model successfully predicts the influence of key operating parameters including total flow rate, flow rate ratio, and lipid concentration, demonstrating favorable comparison with experimental results and enabling the development of predictive manufacturing processes for consistent critical quality attributes. The mechanistic understanding provides the foundation necessary to optimize manufacturing of LNPs used as delivery agents of mRNA vaccines, which extends beyond the current application to the broader field of nucleic acid therapeutics.
- 15 September 2025
- Published by American Chemical Society (ACS) in ACS Nano
Manufacturing mRNA-Loaded Lipid Nanoparticles with Precise Size and Morphology Control
Lipid nanoparticles (LNPs) are the leading platform for delivering nucleic acid therapeutics, produced by rapidly mixing lipids in ethanol with nucleic acid cargo in an aqueous buffer. LNP production is often approached with a mixing-focused mindset that reduces the entire self-assembly process to a single step, obscuring the relationship between the process inputs and LNP properties. Here, we present a method for producing mRNA-loaded LNPs, with independent and predictive control over both the size and morphology and without compromising other quality attributes. By decoupling particle design from mixing and formulation changes, this method enables the rational engineering of LNPs with defined properties. The method leverages mixing under high fusogenicity conditions, achieved by modulating the solvent composition, followed by timed postinjection of an aqueous buffer to kinetically arrest LNPs at the desired properties. We demonstrate the method using benchmark LNP formulations in an impinging jet mixer, a state-of-the-art technology for LNP manufacturing. The resulting LNPs exhibit up to an 8-fold increase in in vitro transfection efficacy compared to those produced by the conventional method. In addition, the method facilitates quality control and supports predictive modeling and rational process translation.
- 15 September 2025
- Published by American Chemical Society (ACS) in ACS Nano
Manufacturing mRNA-Loaded Lipid Nanoparticles with Precise Size and Morphology Control
Lipid nanoparticles (LNPs) are the leading platform for delivering nucleic acid therapeutics, produced by rapidly mixing lipids in ethanol with nucleic acid cargo in an aqueous buffer. LNP production is often approached with a mixing-focused mindset that reduces the entire self-assembly process to a single step, obscuring the relationship between the process inputs and LNP properties. Here, we present a method for producing mRNA-loaded LNPs, with independent and predictive control over both the size and morphology and without compromising other quality attributes. By decoupling particle design from mixing and formulation changes, this method enables the rational engineering of LNPs with defined properties. The method leverages mixing under high fusogenicity conditions, achieved by modulating the solvent composition, followed by timed postinjection of an aqueous buffer to kinetically arrest LNPs at the desired properties. We demonstrate the method using benchmark LNP formulations in an impinging jet mixer, a state-of-the-art technology for LNP manufacturing. The resulting LNPs exhibit up to an 8-fold increase in in vitro transfection efficacy compared to those produced by the conventional method. In addition, the method facilitates quality control and supports predictive modeling and rational process translation.
- Open Access
- 11 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (40) , 33278-33296
FlowMat: a toolbox for modeling flow reactors using physics-based and machine learning approaches for modular simulation, parameter identification, and reactor optimization
This paper introduces a versatile, open-source MATLAB/Simulink toolbox for modeling and optimizing flow reactors. The toolbox features a modular architecture and an intuitive drag-and-drop interface, supporting a range of different modeling approaches, including physics-based, data-driven, and hybrid models such as physics-informed neural networks. We detail the toolbox's implementation and demonstrate its capabilities through real-world applications, including the simulation of flow reactors, identification of reaction parameters using experimental data (e.g., transient data), and optimization of reactor operating points and configurations. Experimental validations illustrate the practical applicability and effectiveness of the toolbox, making it a valuable resource for researchers and engineers in the field with the potential of reducing the cost and time required for parameter determination and reactor optimization.
- 11 September 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (40) , 33278-33296
Open AccessFlowMat: a toolbox for modeling flow reactors using physics-based and machine learning approaches for modular simulation, parameter identification, and reactor optimization
This paper introduces a versatile, open-source MATLAB/Simulink toolbox for modeling and optimizing flow reactors. The toolbox features a modular architecture and an intuitive drag-and-drop interface, supporting a range of different modeling approaches, including physics-based, data-driven, and hybrid models such as physics-informed neural networks. We detail the toolbox's implementation and demonstrate its capabilities through real-world applications, including the simulation of flow reactors, identification of reaction parameters using experimental data (e.g., transient data), and optimization of reactor operating points and configurations. Experimental validations illustrate the practical applicability and effectiveness of the toolbox, making it a valuable resource for researchers and engineers in the field with the potential of reducing the cost and time required for parameter determination and reactor optimization.
- Top Cited Papers
- 3 June 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (23) , 21206-21242
Structure and Morphology of Lipid Nanoparticles for Nucleic Acid Drug Delivery: A Review
Lipid nanoparticles (LNPs) are a clinically proven platform for protecting and delivering nucleic acid-based therapeutics. These multicomponent particles self-assemble into a core-shell structure with the nucleic acid cargo encapsulated in its core. Despite considerable research efforts to establish structure-efficacy relationships, their morphological and structural characteristics─particularly their internal composition and distribution─remain elusive. This uncertainty arises from several factors, including challenges in characterization, the dynamic nature of LNPs, sample heterogeneity, and poorly understood formulation-structure relationships. This review highlights the current state of research on the structure and morphology of LNPs, characterization techniques, and ongoing efforts to elucidate how formulation parameters affect the structural and morphological LNP properties.
- 3 June 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (23) , 21206-21242
Top Cited PapersStructure and Morphology of Lipid Nanoparticles for Nucleic Acid Drug Delivery: A Review
Lipid nanoparticles (LNPs) are a clinically proven platform for protecting and delivering nucleic acid-based therapeutics. These multicomponent particles self-assemble into a core-shell structure with the nucleic acid cargo encapsulated in its core. Despite considerable research efforts to establish structure-efficacy relationships, their morphological and structural characteristics─particularly their internal composition and distribution─remain elusive. This uncertainty arises from several factors, including challenges in characterization, the dynamic nature of LNPs, sample heterogeneity, and poorly understood formulation-structure relationships. This review highlights the current state of research on the structure and morphology of LNPs, characterization techniques, and ongoing efforts to elucidate how formulation parameters affect the structural and morphological LNP properties.
- Open Access
- 1 July 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (31) , 12523-12533
Simultaneous reaction- and analytical model building using dynamic flow experiments to accelerate process development
By making use of a flow standard addition approach and dynamic flow experiments, we present an automated workflow for the fitting of analytical and reaction models, followed by in silico optimization, within one working day.
- 1 July 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 15 (31) , 12523-12533
Open AccessSimultaneous reaction- and analytical model building using dynamic flow experiments to accelerate process development
By making use of a flow standard addition approach and dynamic flow experiments, we present an automated workflow for the fitting of analytical and reaction models, followed by in silico optimization, within one working day.
- Open Access
- 5 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
An Automated Dual Modeling Approach to Accelerate Reaction Analysis and Optimization
In modern pharmaceutical research, the demand for expeditious development of synthetic routes to active pharmaceutical ingredients (APIs) has led to a paradigm shift towards data-rich process development. Conventional methodologies en-compass prolonged timelines for reaction and analytical model developments. Both method developments are separated into different departments and often require an iterative process to optimize the models. Addressing this issue, we intro-duce an innovative dual modeling approach, seamlessly integrating the development of a Process Analytical Technology (PAT) strategy with reaction optimization. This integrated approach is exemplified in diverse amidation reactions and the synthesis of the API benznidazole. The platform, characterized by a high degree of automation and minimal operator in-volvement, achieves PAT calibration through a “standard addition” approach. Dynamic experiments are executed to screen a broad process space and gather data for fitting kinetic parameters. Employing a Julia-coded software program facilitates rapid kinetic parameter fitting and in-situ optimization within minutes. This highly automated workflow not only expedites the understanding and optimization of chemical processes, but also holds significant promise for time and resource savings within the pharmaceutical industry.
- 5 March 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessAn Automated Dual Modeling Approach to Accelerate Reaction Analysis and Optimization
In modern pharmaceutical research, the demand for expeditious development of synthetic routes to active pharmaceutical ingredients (APIs) has led to a paradigm shift towards data-rich process development. Conventional methodologies en-compass prolonged timelines for reaction and analytical model developments. Both method developments are separated into different departments and often require an iterative process to optimize the models. Addressing this issue, we intro-duce an innovative dual modeling approach, seamlessly integrating the development of a Process Analytical Technology (PAT) strategy with reaction optimization. This integrated approach is exemplified in diverse amidation reactions and the synthesis of the API benznidazole. The platform, characterized by a high degree of automation and minimal operator in-volvement, achieves PAT calibration through a “standard addition” approach. Dynamic experiments are executed to screen a broad process space and gather data for fitting kinetic parameters. Employing a Julia-coded software program facilitates rapid kinetic parameter fitting and in-situ optimization within minutes. This highly automated workflow not only expedites the understanding and optimization of chemical processes, but also holds significant promise for time and resource savings within the pharmaceutical industry.